Evans School Policy Analysis & Research Group (EPAR)

This literature review provides a summary of the risks that potentially limit private sector agribusiness investment in Sub-Saharan Africa (SSA), and some responses to those risks. The report reviews risks that limit private sector investment and interventions used to mitigate risk to agricultural investment including government policy, international financial institutions, philanthropic efforts and other private initiatives. Risk is defined as a potential negative impact to assets, investments, or profitability of investments in the agricultural industry that may arise from some present process or future event. There is currently limited information examining how particular risk factors influence private-sector agribusiness investment in the region. However, the information that is available suggests that economic and political instability are among the most significant risks to agribusiness investors in SSA. Further, the literature notes that agricultural risks in SSA are particularly pronounced due to environmental risks that contribute to unreliable cash flows and uncertain profitability. We find that these risk factors are compounded by a lack of data and information for investors to use in assessing and pricing risks appropriately. 

This report provides a general overview of trends in public and private agricultural research and development (R&D) funding and expenditures in Sub-Saharan Africa (SSA). The request is divided into two sections, covering public funding and private funding. Within each section, relevant data is presented on historical funding patterns, the types of research conducted, and which countries within SSA are financing R&D at the highest level. We find that the majority of growth in African public agricultural research funding took place in the 1960s, when real public spending on agricultural research increased 6% a year. From 1971 to 2000 annual growth averaged 1.4% a year. Public financing of agricultural R&D experienced a moderate shift in the 1990s from bilateral and multilateral donor funding to domestic government financing. The shift varied by country, but donor funding dropped for all SSA countries an average of 10%. Private research and development funding is heavily concentrated in developed countries with the United States and Japan the two biggest spenders. Within SSA, private R&D expenditures comprise 2% of all R&D spending. The main private actors in SSA are companies based in South Africa and Nigeria. The private sector is focused on research areas that involve marketable inputs, such as chemicals, seeds, and machines/